Psp Research Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$141.3M
Q ending 2026-03-31
Prior quarter
$114.4M
Q ending 2025-12-31
Change
+23.5% QoQ
Positions
79
reported holdings
Largest positions
All 79 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Ishares Tr | SGOV | Shares | $70.5M | 700K |
| Spdr Series Trust | XBI | Shares | $36.4M | 285K |
| Sera Prognostics Inc | SERA | Shares | $4.9M | 2.4M |
| Definium Therapeutics Inc | DFTX | Shares | $658K | 35K |
| Tyra Biosciences Inc | TYRA | Shares | $613K | 16K |
| Ascendis Pharma A/S | Shares | $572K | 3K | |
| Pharvaris N V | Shares | $565K | 20K | |
| Cytokinetics Inc | CYTK | Shares | $547K | 8K |
| Royalty Pharma Plc | Shares | $528K | 11K | |
| Kymera Therapeutics Inc | KYMR | Shares | $525K | 6K |
| Halozyme Therapeutics Inc | HALO | Shares | $519K | 8K |
| Exelixis Inc | EXEL | Shares | $512K | 12K |
| Disc Medicine Inc | IRON | Shares | $512K | 8K |
| Ionis Pharmaceuticals Inc | IONS | Shares | $511K | 7K |
| Agios Pharmaceuticals Inc | AGIO | Shares | $507K | 15K |
| Neurocrine Biosciences Inc | NBIX | Shares | $507K | 4K |
| Incyte Corp | INCY | Shares | $499K | 5K |
| Tarsus Pharmaceuticals Inc | TARS | Shares | $491K | 7K |
| Viking Therapeutics Inc | VKTX | Shares | $488K | 15K |
| Alnylam Pharmaceuticals Inc | ALNY | Shares | $485K | 1K |
| Praxis Precision Medicines I | PRAX | Shares | $483K | 2K |
| Axsome Therapeutics Inc. | AXSM | Shares | $481K | 3K |
| Newamsterdam Pharma Company | Shares | $480K | 15K | |
| Ardelyx Inc | ARDX | Shares | $479K | 80K |
| Immunovant Inc | IMVT | Shares | $477K | 19K |
| Argenx Se | ARGX | Shares | $468K | 641 |
| Syndax Pharmaceuticals Inc | SNDX | Shares | $467K | 20K |
| Inhibrx Biosciences Inc | INBX | Shares | $466K | 7K |
| Arcutis Biotherapeutics Inc | ARQT | Shares | $464K | 20K |
| Ultragenyx Pharmaceutical In | RARE | Shares | $463K | 22K |
| Mirum Pharmaceuticals Inc | MIRM | Shares | $462K | 5K |
| Cogent Biosciences Inc | COGT | Shares | $462K | 12K |
| Monte Rosa Therapeutics Inc | GLUE | Shares | $461K | 28K |
| Immunocore Hldgs Plc | IMCR | Shares | $457K | 15K |
| Crispr Therapeutics Ag | Shares | $452K | 10K | |
| Bridgebio Pharma Inc | BBIO | Shares | $446K | 6K |
| Nurix Therapeutics Inc | NRIX | Shares | $445K | 29K |
| Aurinia Pharmaceuticals Inc | AUPH | Shares | $445K | 30K |
| Acadia Pharmaceuticals Inc | ACAD | Shares | $440K | 20K |
| Rapport Therapeutics Inc | RAPP | Shares | $438K | 14K |
| Immunome Inc | IMNM | Shares | $437K | 20K |
| Kiniksa Pharmaceuticals Intl | Shares | $433K | 9K | |
| Tg Therapeutics Inc | TGTX | Shares | $432K | 13K |
| Dianthus Therapeutics Inc | DNTH | Shares | $420K | 5K |
| Celldex Therapeutics Inc New | CLDX | Shares | $412K | 13K |
| Ptc Therapeutics Inc | PTCT | Shares | $409K | 6K |
| Vera Therapeutics Inc | VERA | Shares | $402K | 10K |
| Harmony Biosciences Hldgs In | HRMY | Shares | $400K | 14K |
| Crinetics Pharmaceuticals In | CRNX | Shares | $400K | 11K |
| Compass Pathways Plc | CMPS | Shares | $393K | 71K |
| Stoke Therapeutics Inc | STOK | Shares | $391K | 12K |
| Kodiak Sciences Inc | KOD | Shares | $381K | 10K |
| Dyne Therapeutics Inc | DYN | Shares | $363K | 20K |
| Trevi Therapeutics Inc | TRVI | Shares | $358K | 30K |
| Intellia Therapeutics Inc | NTLA | Shares | $345K | 27K |
| Protagonist Therapeutics Inc | PTGX | Shares | $316K | 3K |
| Madrigal Pharmaceuticals Inc | MDGL | Shares | $314K | 600 |
| Supernus Pharmaceuticals | SUPN | Shares | $310K | 6K |
| Tango Therapeutics Inc | TNGX | Shares | $301K | 14K |
| Erasca Inc | ERAS | Shares | $280K | 17K |
| Enliven Therapeutics Inc | ELVN | Shares | $274K | 7K |
| Spyre Therapeutics Inc | SYRE | Shares | $260K | 5K |
| Zymeworks Inc | ZYME | Shares | $250K | 10K |
| Xenon Pharmaceuticals Inc | XENE | Shares | $244K | 4K |
| Oruka Therapeutics Inc | ORKA | Shares | $244K | 5K |
| Celcuity Inc | CELC | Shares | $228K | 2K |
| Kalvista Pharmaceuticals Inc | 4XC1 | Shares | $217K | 11K |
| Legend Biotech Corp | LEGN | Shares | $217K | 12K |
| Alkermes Plc | Shares | $212K | 6K | |
| Apogee Therapeutics Inc | APGE | Shares | $210K | 3K |
| United Therapeutics Corp Del | UTHR | Shares | $208K | 350 |
| Edgewise Therapeutics Inc | EWTX | Shares | $205K | 7K |
| Summit Therapeutics Inc | SMMT | Shares | $194K | 10K |
| Oric Pharmaceuticals Inc | ORIC | Shares | $165K | 13K |
| Compass Therapeutics Inc | CMPX | Shares | $159K | 30K |
| Amylyx Pharmaceuticals Inc | AMLX | Shares | $151K | 11K |
| Olema Pharmaceuticals Inc | OLMA | Shares | $149K | 10K |
| Eyepoint Inc | EYPT | Shares | $129K | 10K |
| Ocular Therapeutix Inc | OCUL | Shares | $127K | 15K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.